Association Between GLP-1 Receptor Agonists, Other Antidiabetic Drugs, and Diabetic Microvascular Complications: A Mendelian Randomization Analysis
Current medicinal chemistry · 2026 Oct 19 · Liu R, Tang S, Li S et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 18 20:00 ETSource: Current medicinal chemistry
From the source
Read at pubmed.ncbi.nlm.nih.govAssociation Between GLP-1 Receptor Agonists, Other Antidiabetic Drugs, and Diabetic Microvascular Complications: A Mendelian Randomization Analysis
Current medicinal chemistry · 2026 Oct 19 · Liu R, Tang S, Li S et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42973323/
